WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

HUTCHINSON-GILFORD PROGERIA SYNDROME-A RARE GENETIC DISORDER

Kanchan Lata Gupta*, Shashi Pratap Singh, Noopur Srivastava, Anurag Shukla, Chandra Shekhar Bhargava and Cheenu Bhargava

ABSTRACT

Progeria is also known as Hutchinson Gilford Progeria Syndrome. It is described by Jonathan Hutchinson and Hasting Gilford. The word Progeria obtained from the Greek word “pro” means “before” and “geras” means “agedness”. It is a genetic disorder, not inherited. It is identify by facial appearance containing prominent eye, thin nose, small chin and thin lip. The symptoms of progeria may includes alopecia(hair loss), low body weight, decrease joint motility, facial appearance that are similar to old age person and accelerated cardiovascular disease. It is caused due to mutation in LMNA gene in which cysteine is replaced by thymine. This gene is important for producing Lamin A and Lamin C proteins. Treatment includes aspirin may helps to prevent antithrombotic events and cardiovascular disease. Hydrotherapy may be used to improve joint mobility and sign and symptoms of arthritis. FTIs (farnesyl transferase inhibitors) is used to decrease the severity of disease. FTIs is effective by blocking the farnesylation of progerin. Fluoride and vitamin supplements are recommend for progeria patients.

Keywords: Progeria, alopecia, cerebrovascular, Rapamycin, Lamin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More